Skip to main content

Archived Comments for: Malaria vaccine efficacy: the difficulty of detecting and diagnosing malaria

Back to article

  1. Errata - missing references

    Wendy Prudhomme O'Meara, Fogarty International Center, NIH

    5 June 2008

    References after number 22 seem to have been dropped from the reference section during the production process. I am pasting the complete list of references here, with numbering corresponding to the text. Apologies for any inconvenience.


    1. Smith PG, Rodrigues LC, Fine PEM: Assessment of the Protective Efficacy of Vaccines against Common Diseases Using Case-Control and Cohort Studies. Int J Epidemiol 1984, 13:87-93.

    2. Blackwelder WC, Storsaeter J, Olin P, Hallander HO: Acellular Pertussis Vaccines - Efficacy and Evaluation of Clinical Case Definitions. Am J Dis Child 1991, 145:1285-1289.

    3. Lachenbruch PA: Sensitivity, specificity, and vaccine efficacy. Control Clin Trials 1998, 19:569-574.

    4. Prudhomme O'Meara W, Barcus M, Wongsrichanalai C, Muth S, Maguire J, Jordan R, Prescott WR, McKenzie FE: Reader technique as a source of variability in determining malaria parasite density by microscopy. Malaria Journal 2006, 5:118.

    5. Bejon P, Andrews L, Andersen RF, Dunachie S, Webster D, Walther M, Gilbert SC, Peto T, Hill AVS: Calculation of liver-to-blood inocula, parasite growth rates, and preerythrocytic vaccine efficacy, from serial quantitative polymerase chain reaction studies of volunteers challenged with malaria sporozoites. J Infect Dis 2005, 191:619-626.

    6. McKenzie FE, Sirichaisinthop J, Miller RS, Gasser RA, Wongsrichanalai C: Dependence of malaria detection and species diagnosis by microscopy on parasite density. Am J Trop Med Hyg 2003, 69:372-376.

    7. Ohrt C, Purnomo, Sutamihardja MA, Tang D, Kain KC: Impact of Microscopy error on estimates of protective efficacy in malaria-prevention trials. J Infect Dis 2002, 186:540-546.

    8. O'Meara WP, McKenzie FE, Magill AJ, Forney JR, Permpanich B, Lucas C, Gasser RA, Wongsrichanalai C: Sources of variability in determining malaria parasite density by microscopy. Am J Trop Med Hyg 2005, 73:593-598.

    9. Genton B, Betuela I, Felger I, Al-Yaman F, Anders RF, Saul A, Rare L, Baisor M, Lorry K, Brown GV, et al: A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1-2b trial in Papua New Guinea. J Infect Dis 2002, 185:820-827.

    10. Forney JR, Wongsrichanalai C, Magill AJ, Craig LG, Sirichaisinthop J, Bautista CT, Miller RS, Ockenhouse CF, Kester KE, Aronson NE, et al: Devices for rapid diagnosis of malaria: Evaluation of prototype assays that detect Plasmodium falciparum histidine-rich protein 2 and a Plasmodium vivax-specific antigen. J Clin Microbiol 2003, 41:2358-2366.

    11. Forney JR, Magill AJ, Wongsrichanalai C, Sirichaisinthop J, Bautista CT, Heppner DG, Miller RS, Ockenhouse CF, Gubanov A, Shafer R, et al: Malaria rapid diagnostic devices: Performance characteristics of the ParaSight F device determined in a multisite field study. J Clin Microbiol 2001, 39:2884-2890.

    12. Warhurst DC, Williams JE: Laboratory diagnosis of malaria. J Clin Pathol 1996, 49:533-538.

    13. Rogier C, Commenges D, Trape JF: Evidence for an age-dependent pyrogenic threshold of Plasmodium falciparum parasitemia in highly endemic populations. Am J Trop Med Hyg 1996, 54:613-619.

    14. McKenzie FE, Prudhomme WA, Magill AJ, Forney JR, Permpanich B, Lucas C, Gasser RA, Wongsrichanalai C: White blood cell counts and malaria. J Infect Dis 2005, 192:323-330.

    15. Nosten F, Luxemburger C, Kyle DE, Ballou WR, Wittes J, Wah E, Chongsuphajaisiddhi T, Gordon DM, White NJ, Sadoff JC, et al: Randomised double-blind placebo-controlled trial of SPf66 malaria vaccine in children in northwestern Thailand. Lancet 1996, 348:701-707.

    16. D'Alessandro U, Leach A, Drakeley CJ, Bennett S, Olaleye BO, Fegan GW, Jawara M, Langerock P, George MO, Targett GAT, Greenwood BM: Efficacy Trial of Malaria Vaccine Spf66 in Gambian Infants. Lancet 1995, 346:462-467.

    17. Planche T, Krishna S, Kombila M, Engel K, Faucher JF, Ngou-Milama E, Kremsner PG: Comparison of methods for the rapid laboratory assessment of children with malaria. Am J Trop Med Hyg 2001, 65:599-602.

    18. Genton B, Alyaman F, Alpers MP: Assessment of Malaria Morbidity in Vaccine Efficacy Trials. Lancet 1995, 345:804-804.

    19. Delley V, Bouvier P, Breslow N, Doumbo O, Sagara I, Diakite M, Mauris A, Dolo A, Rougemont A: What does a single determination of malaria parasite density mean? A longitudinal survey in Mali. Trop Med Int Health 2000, 5:404-412.

    20. Farnert A, Snounou G, Rooth I, Bjorkman A: Daily dynamics of Plasmodium falciparum subpopulations in asymptomatic children in a holoendemic area. Am J Trop Med Hyg 1997, 56:538-547.

    21. Smith T, Schellenberg JA, Hayes R: Attributable Fraction Estimates and Case Definitions for Malaria in Endemic Areas. Stat Med 1994, 13:2345-2358.

    22. Mwangi TW, Ross A, Snow RW, Marsh K: Case definitions of clinical malaria under different transmission conditions in Kilifi District, Kenya. J Infect Dis 2005, 191:1932-1939.

    23. Dicko A, Mantel C, Kouriba B, Sagara I, Thera MA, Doumbia S, Diallo M, Poudiougou B, Diakite M, Doumbo OK: Season, fever prevalence and pyrogenic threshold for malaria disease definition in an endemic area of Mali. Trop Med Int Health 2005, 10:550-556.

    24. McGuinness D, Koram K, Bennett S, Wagner G, Nkrumah F, Riley E: Clinical case definitions for malaria: clinical malaria associated with very low parasite densities in African infants. Trans R Soc Trop Med Hyg 1998, 92:527-531.

    25. Trape JF, Peelman P, Moraultpeelman B: Criteria for Diagnosing Clinical Malaria among a Semi-Immune Population Exposed to Intense and Perennial Transmission. Trans R Soc Trop Med Hyg 1985, 79:435-442.

    26. Ladhani S, Lowe B, Cole AO, Kowuondo K, Newton C: Changes in white blood cells and platelets in children with falciparum malaria: relationship to disease outcome. Br J Haematol 2002, 119:839-847.

    27. Rogers WO, Atuguba F, Oduro AR, Hodgson A, Koram KA: Clinical case definitions and malaria vaccine efficacy. J Infect Dis 2006, 193:467-473.

    28. Henry MC, Assi SB, Rogier C, Dossou-Yovo J, Chandre F, Guillet P, Carnevale P: Protective efficacy of lambda-cyhalothrin treated nets in Anopheles gambiae pyrethroid resistance areas of Cote d'Ivoire. Am J Trop Med Hyg 2005, 73:859-864.

    29. Vounatsou P, Smith T, Kitua AY, Alonso PL, Tanner M: Apparent tolerance of Plasmodium falciparum in infants in a highly endemic area. Parasitology 2000, 120:1-9.

    30. Stoute JA, Slaoui M, Heppner DG, Momin P, Kester KE, Desmons P, Wellde BT, Garcon N, Krzych U, Marchand M, et al: A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. N Engl J Med 1997, 336:86-91.

    31. Kester KE, McKinney DA, Tornieporth N, Ockenhouse CF, Heppner DG, Hall T, Krzych U, Delchambre M, Voss G, Dowler MG, et al: Efficacy of recombinant circumsporozoite protein vaccine regimens against experimental Plasmodium falciparum malaria. J Infect Dis 2001, 183:640-647.

    32. Hoffman SL, Edelman R, Bryan JP, Schneider I, Davis J, Sedegah M, Gordon D, Church P, Gross M, Silverman C, et al: Safety, Immunogenicity, and Efficacy of a Malaria Sporozoite Vaccine Administered with Monophosphoryl Lipid a, Cell-Wall Skeleton of Mycobacteria, and Squalane as Adjuvant. Am J Trop Med Hyg 1994, 51:603-612.

    33. Ockenhouse CF, Sun PF, Lanar DE, Wellde BT, Hall BT, Kester K, Stoute JA, Magill A, Krzych U, Farley L, et al: Phase I/IIa safety, immunogenicity, and efficacy trial of NYVAC-Pf7, a pox-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria. J Infect Dis 1998, 177:1664-1673.

    34. Webster DP, Dunachie S, Vuola JM, Berthoud T, Keating S, Laidlaw SM, McConkey SJ, Poulton I, Andrews L, Andersen RF, et al: Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus Ankara. Proc Natl Acad Sci U S A 2005, 102:4836-4841.

    35. Bojang KA, Milligan PJM, Pinder M, Vigneron L, Alloueche A, Kester KE, Ballou WR, Conway DJ, Reece WHH, Gothard P, et al: Efficacy of RTS,S/ASO2 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial. Lancet 2001, 358:1927-1934.

    36. Alonso PL, Sacarlal J, Aponte JJ, Leach A, Macete E, Milman J, Mandomando I, Spiessens B, Guinovart C, Espasa M, et al: Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial. Lancet 2004, 364:1411-1420.

    37. Alonso PL, Smith T, Schellenberg J, Masanja H, Mwankusye S, Urassa H, Deazevedo IB, Chongela J, Kobero S, Menendez C, et al: Randomized Trial of Efficacy of Spf66 Vaccine against Plasmodium-Falciparum Malaria in Children in Southern Tanzania. Lancet 1994, 344:1175-1181.

    38. Maguire J, Lederman E, Barcus M, Prudhomme O'Meara W, Jordon R, Duong S, Muth S, Sismadi P, Bangs M, Prescott W, et al: Production and Validation of Durable, High Quality Standardized Malaria Microscopy Slides for Teaching, Testing and Quality Assurance during an Era of Declining Diagnostic Proficiency. Malaria Journal 2006, 5:92.

    Competing interests

    No competing interests